PhD Medical Microbiology, University of Aberdeen, Scotland. 1995.
MSc Biochemistry, University of Dundee, Scotland. 1990.
BSc (Hons) Biological Sciences, University of Stirling, Scotland. 1989.
Lead advisor to Synthetic Genomics Vaccine Inc. La Jolla, CA. USA. (June 2013 - 2015).
Research Director, AmpliPhi Biosciences Corporation, Colworth Science Park, Sharnbrook, UK and Virginia BioTechnology Research Park, Richmond, USA. (May 2010 – June 2012).
Professor, Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, UK (September 2007 – March 2010).
Director, Intelligent Fabric Technologies plc. (May 2008 – Nov 2010).
Reader, Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, UK Imperial College London, UK (July 2005 – September 2007).
Reader / Senior research fellow and Royal Society University Research Fellow, University of Bath, UK (September 2000 – June 2005).
Postdoctoral research fellow - University of Oxford, UK (February 1997–September 2000); University of Sussex, UK (November 1994–February 1997).
Infectious Disease Epidemiology
Evolution
Microbial Genomics
Infectious Disease
Antibiotic Resistance
Bacteriophage Biology
G. Blundell-Hunter, MC. Enright, D. Negus, MJ. Dorman, GE. Beecham, et al. DJ. Pickard, P. Wintachai, SP. Voravuthikunchai, NR. Thomson, PW. Taylor. (2021). Characterisation of Bacteriophage-Encoded Depolymerases Selective for Key Klebsiella pneumoniae Capsular Exopolysaccharides. Frontiers in Cellular and Infection Microbiology. 11,
J. Redfern, MC. Enright (2020). Further understanding of Pseudomonas aeruginosa’s ability to horizontally acquire virulence: possible intervention strategies. Expert Review of Anti-Infective Therapy. 18(6), pp.539-549.
M. Jaillard, A. van Belkum, KC. Cady, D. Creely, D. Shortridge, et al. B. Blanc, EM. Barbu, WM. Dunne, G. Zambardi, M. Enright, N. Mugnier, C. Le Priol, S. Schicklin, G. Guigon, J-B. Veyrieras. (2017). Correlation between phenotypic antibiotic susceptibility and the resistome in Pseudomonas aeruginosa. International Journal of Antimicrobial Agents. 50(2), pp.210-218.
X. Li, C. Koç, P. Kühner, YD. Stierhof, B. Krismer, et al. MC. Enright, JR. Penadés, C. Wolz, T. Stehle, C. Cambillau, A. Peschel, G. Xia. (2016). An essential role for the baseplate protein Gp45 in phage adsorption to Staphylococcus aureus. Scientific Reports. 6,
JE. Bean, DR. Alves, M. Laabei, PP. Esteban, NT. Thet, et al. MC. Enright, ATA. Jenkins. (2014). Triggered Release of Bacteriophage K from Agarose/Hyaluronan Hydrogel Matrixes by Staphylococcus aureus Virulence Factors. Chemistry of Materials. 26(24), pp.7201-7208.
DR. Alves, A. Gaudion, JE. Bean, P. Perez Esteban, TC. Arnot, et al. DR. Harper, W. Kot, LH. Hansen, MC. Enright, ATA. Jenkins. (2014). Combined use of bacteriophage K and a novel bacteriophage to reduce Staphylococcus aureus biofilm formation. Appl Environ Microbiol. 80(21), pp.6694-6703.
PP. Esteban, DR. Alves, MC. Enright, JE. Bean, A. Gaudion, et al. ATA. Jenkins, AER. Young, TC. Arnot. (2014). Enhancement of the antimicrobial properties of bacteriophage-K via stabilization using oil-in-water nano-emulsions. Biotechnol Prog. 30(4), pp.932-944.
CR. Murphy, LO. Hudson, BG. Spratt, K. Elkins, L. Terpstra, et al. A. Gombosev, C. Nguyen, P. Hannah, R. Alexander, MC. Enright, SS. Huang. (2013). Predictors of hospitals with endemic community-associated methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol. 34(6), pp.581-587.
MC. Rehfuss, LA. Underwood, M. Enright, S. Hill, R. Marshall, et al. P. Tipton, L. West, K. Warren. (2013). Treatment impact of an integrated sex offender program as measured by J-SOAP-II. J Correct Health Care. 19(2), pp.113-123.
CR. Murphy, LO. Hudson, BG. Spratt, V. Quan, D. Kim, et al. E. Peterson, G. Tan, K. Evans, H. Meyers, M. Cheung, BY. Lee, DB. Mukamel, MC. Enright, M. Whealon, SS. Huang. (2013). Predicting high prevalence of community methicillin-resistant Staphylococcus aureus strains in nursing homes. Infect Control Hosp Epidemiol. 34(3), pp.325-326.
KL. Blake, M. Henry, L. Debarbieux, ML. McConville, IM. Prosser, et al. HM. Parracho, MC. Enright, DR. Harper. (2012). RATIONAL DESIGN OF A PSEUDOMONAS AERUGINOSA BACTERIOPHAGE THERAPEUTIC AND ITS EFFICACY IN A MURINE LUNG INFECTION MODEL. PEDIATRIC PULMONOLOGY. 47, pp.319-319.
J. Larsen, MC. Enright, D. Godoy, BG. Spratt, AR. Larsen, et al. RL. Skov. (2012). Multilocus sequence typing scheme for Staphylococcus aureus: revision of the gmk locus. J Clin Microbiol. 50(7), pp.2538-2539.
CU. Köser, MTG. Holden, MJ. Ellington, EJP. Cartwright, NM. Brown, et al. AL. Ogilvy-Stuart, LY. Hsu, C. Chewapreecha, NJ. Croucher, SR. Harris, M. Sanders, MC. Enright, G. Dougan, SD. Bentley, J. Parkhill, LJ. Fraser, JR. Betley, OB. Schulz-Trieglaff, GP. Smith, SJ. Peacock. (2012). Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N Engl J Med. 366(24), pp.2267-2275.
PR. McAdam, KE. Templeton, GF. Edwards, MTG. Holden, EJ. Feil, et al. DM. Aanensen, HJA. Bargawi, BG. Spratt, SD. Bentley, J. Parkhill, MC. Enright, A. Holmes, EK. Girvan, PA. Godfrey, M. Feldgarden, AM. Kearns, A. Rambaut, DA. Robinson, JR. Fitzgerald. (2012). Molecular tracing of the emergence, adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A. 109(23), pp.9107-9112.
LO. Hudson, CR. Murphy, BG. Spratt, MC. Enright, L. Terpstra, et al. A. Gombosev, P. Hannah, L. Mikhail, R. Alexander, DF. Moore, SS. Huang. (2012). Differences in methicillin-resistant Staphylococcus aureus strains isolated from pediatric and adult patients from hospitals in a large county in California. J Clin Microbiol. 50(3), pp.573-579.
HM. Parracho, BH. Burrowes, MC. Enright, ML. McConville, DR. Harper (2012). The role of regulated clinical trials in the development of bacteriophage therapeutics. Journal of molecular and genetic medicine : an international journal of biomedical research. 6, pp.279-286.
DR. Harper, J. Anderson, MC. Enright (2011). Erratum. Therapeutic Delivery. 2(10), pp.1372-1372.
B. Burrowes, DR. Harper, J. Anderson, M. McConville, MC. Enright (2011). Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens. Expert Rev Anti Infect Ther. 9(9), pp.775-785.
DR. Harper, J. Anderson, MC. Enright (2011). Phage therapy: delivering on the promise. Ther Deliv. 2(7), pp.935-947.
DR. Harper, MC. Enright (2011). Bacteriophages for the treatment of Pseudomonas aeruginosa infections. J Appl Microbiol. 111(1), pp.1-7.
DR. Harper, MC. Enright (2011). Bacteriophages for the treatment of Pseudomonas aeruginosa infections. Journal of Applied Microbiology.
MC. Enright, BG. Spratt (2011). Genomics. The genomic view of bacterial diversification. Science. 331(6016), pp.407-409.
V. Simpson, N. Davison, L. Hudson, AM. Whatmore (2010). Staphylococcus aureus ST49 infection in red squirrels. Vet Rec. 167(2), pp.69-69.
MC. Enright (2010). ACTIVITY AND VIABILITY FOLLOWING AEROLIZATION OF PSEUDOMONAS AERUGINOSA BACTERIOPHAGE AGAINST CLINICAL ISOLATES FROM CYSTIC FIBROSIS PATIENTS. PEDIATRIC PULMONOLOGY. pp.311-312.
. International Working Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC) (2009). Classification of staphylococcal cassette chromosome mec (SCCmec): guidelines for reporting novel SCCmec elements. Antimicrob Agents Chemother. 53(12), pp.4961-4967.
DS. Smyth, EJ. Feil, WJ. Meaney, PJ. Hartigan, T. Tollersrud, et al. JR. Fitzgerald, MC. Enright, CJ. Smyth. (2009). Molecular genetic typing reveals further insights into the diversity of animal-associated Staphylococcus aureus. J Med Microbiol. 58(Pt 10), pp.1343-1353.
A. Kalia, MC. Enright, BG. Spratt, DE. Bessen (2009). Retraction. Directional gene movement from human-pathogenic to commensal-like streptococci. Infect Immun. 77(10), pp.4688-4688.
R. Hastings, L. Taylor, P. Phillips (2009). Re: A novel bactericidal fabric coating with potent in vitro activity against meticillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents. 34(1), pp.99-100.
SJ. O'Hanlon, MC. Enright (2009). A novel bactericidal fabric coating with potent in vitro activity against meticillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents. 33(5), pp.427-431.
C. Liu, CJ. Graber, M. Karr, BA. Diep, L. Basuino, et al. BS. Schwartz, MC. Enright, SJ. O'Hanlon, JC. Thomas, F. Perdreau-Remington, S. Gordon, H. Gunthorpe, R. Jacobs, P. Jensen, G. Leoung, JS. Rumack, HF. Chambers. (2008). A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005. Clin Infect Dis. 46(11), pp.1637-1646.
M. Miragaia, JA. Carriço, JC. Thomas, I. Couto, MC. Enright, et al. H. de Lencastre. (2008). Comparison of molecular typing methods for characterization of Staphylococcus epidermidis: proposal for clone definition. J Clin Microbiol. 46(1), pp.118-129.
BD. Cookson, DA. Robinson, AB. Monk, S. Murchan, A. Deplano, et al. R. de Ryck, MJ. Struelens, C. Scheel, V. Fussing, S. Salmenlinna, J. Vuopio-Varkila, C. Cuny, W. Witte, PT. Tassios, NJ. Legakis, W. van Leeuwen, A. van Belkum, A. Vindel, J. Garaizar, S. Haeggman, B. Olsson-Liljequist, U. Ransjo, M. Muller-Premru, W. Hryniewicz, A. Rossney, B. O'Connell, BD. Short, J. Thomas, S. O'Hanlon, MC. Enright. (2007). Evaluation of molecular typing methods in characterizing a European collection of epidemic methicillin-resistant Staphylococcus aureus strains: the HARMONY collection. J Clin Microbiol. 45(6), pp.1830-1837.
M. Miragaia, JC. Thomas, I. Couto, MC. Enright, H. de Lencastre (2007). Inferring a population structure for Staphylococcus epidermidis from multilocus sequence typing data. J Bacteriol. 189(6), pp.2540-2552.
JC. Thomas, MR. Vargas, M. Miragaia, SJ. Peacock, GL. Archer, et al. MC. Enright. (2007). Improved multilocus sequence typing scheme for Staphylococcus epidermidis. J Clin Microbiol. 45(2), pp.616-619.
G. Lina, G. Durand, C. Berchich, B. Short, H. Meugnier, et al. F. Vandenesch, J. Etienne, MC. Enright. (2006). Staphylococcal chromosome cassette evolution in Staphylococcus aureus inferred from ccr gene complex sequence typing analysis. Clin Microbiol Infect. 12(12), pp.1175-1184.
G. Durand, M. Bes, H. Meugnier, MC. Enright, F. Forey, et al. N. Liassine, A. Wenger, K. Kikuchi, G. Lina, F. Vandenesch, J. Etienne. (2006). Detection of New Methicillin-Resistant Staphylococcus aureus Clones Containing the Toxic Shock Syndrome Toxin 1 Gene Responsible for Hospital- and Community-Acquired Infections in France. Journal of Clinical Microbiology. 44(8), pp.3053-3053.
SA. Huws, AW. Smith, MC. Enright, PJ. Wood, MRW. Brown (2006). Amoebae promote persistence of epidemic strains of MRSA. Environ Microbiol. 8(6), pp.1130-1133.
MC. Enright (2006). Genome of an epidemic community-acquired MRSA. Lancet. 367(9512), pp.705-706.
G. Durand, M. Bes, H. Meugnier, MC. Enright, F. Forey, et al. N. Liassine, A. Wenger, K. Kikuchi, G. Lina, F. Vandenesch, J. Etienne. (2006). Detection of new methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital- and community-acquired infections in France. J Clin Microbiol. 44(3), pp.847-853.
M. Aires-de-Sousa, K. Boye, H. de Lencastre, A. Deplano, MC. Enright, et al. J. Etienne, A. Friedrich, D. Harmsen, A. Holmes, XW. Huijsdens, AM. Kearns, A. Mellmann, H. Meugnier, JK. Rasheed, E. Spalburg, B. Strommenger, MJ. Struelens, FC. Tenover, J. Thomas, U. Vogel, H. Westh, J. Xu, W. Witte. (2006). High interlaboratory reproducibility of DNA sequence-based typing of bacteria in a multicenter study. J Clin Microbiol. 44(2), pp.619-621.
BRD. Short, MA. Vargas, JC. Thomas, S. O'Hanlon, MC. Enright (2006). In vitro activity of a novel compound, the metal ion chelating agent AQ+, against clinical isolates of Staphylococcus aureus. J Antimicrob Chemother. 57(1), pp.104-109.
DA. Robinson, AB. Monk, JE. Cooper, EJ. Feil, MC. Enright (2005). Evolutionary genetics of the accessory gene regulator (agr) locus in Staphylococcus aureus. J Bacteriol. 187(24), pp.8312-8321.
M. Ip, RWH. Yung, TK. Ng, WK. Luk, C. Tse, et al. P. Hung, M. Enright, DJ. Lyon. (2005). Contemporary methicillin-resistant Staphylococcus aureus clones in Hong Kong. J Clin Microbiol. 43(10), pp.5069-5073.
Y. Katayama, DA. Robinson, MC. Enright, HF. Chambers (2005). Genetic background affects stability of mecA in Staphylococcus aureus. J Clin Microbiol. 43(5), pp.2380-2383.
A. Shore, AS. Rossney, CT. Keane, MC. Enright, DC. Coleman (2005). Seven novel variants of the staphylococcal chromosomal cassette mec in methicillin-resistant Staphylococcus aureus isolates from Ireland. Antimicrob Agents Chemother. 49(5), pp.2070-2083.
DA. Robinson, AM. Kearns, A. Holmes, D. Morrison, H. Grundmann, et al. G. Edwards, FG. O'Brien, FC. Tenover, LK. McDougal, AB. Monk, MC. Enright. (2005). Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone. Lancet. 365(9466), pp.1256-1258.
A. Buckling, J. Neilson, J. Lindsay, R. ffrench-Constant, M. Enright, et al. N. Day, RC. Massey. (2005). Clonal distribution and phase-variable expression of a major histocompatibility complex analogue protein in Staphylococcus aureus. J Bacteriol. 187(8), pp.2917-2919.
M. Enright (2005). On why politics and MRSA don't mix. Health Serv J. 115(5948),
FG. O'Brien, TT. Lim, FN. Chong, GW. Coombs, MC. Enright, et al. DA. Robinson, A. Monk, B. Saïd-Salim, BN. Kreiswirth, WB. Grubb. (2004). Diversity among community isolates of methicillin-resistant Staphylococcus aureus in Australia. J Clin Microbiol. 42(7), pp.3185-3190.
MTG. Holden, EJ. Feil, JA. Lindsay, SJ. Peacock, NPJ. Day, et al. MC. Enright, TJ. Foster, CE. Moore, L. Hurst, R. Atkin, A. Barron, N. Bason, SD. Bentley, C. Chillingworth, T. Chillingworth, C. Churcher, L. Clark, C. Corton, A. Cronin, J. Doggett, L. Dowd, T. Feltwell, Z. Hance, B. Harris, H. Hauser, S. Holroyd, K. Jagels, KD. James, N. Lennard, A. Line, R. Mayes, S. Moule, K. Mungall, D. Ormond, MA. Quail, E. Rabbinowitsch, K. Rutherford, M. Sanders, S. Sharp, M. Simmonds, K. Stevens, S. Whitehead, BG. Barrell, BG. Spratt, J. Parkhill. (2004). Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci U S A. 101(26), pp.9786-9791.
EJ. Feil, MC. Enright (2004). Analyses of clonality and the evolution of bacterial pathogens. Curr Opin Microbiol. 7(3), pp.308-313.
AB. Monk, S. Curtis, J. Paul, MC. Enright (2004). Genetic analysis of Staphylococcus aureus from intravenous drug user lesions. J Med Microbiol. 53(Pt 3), pp.223-227.
DA. Robinson, MC. Enright (2004). Evolution of Staphylococcus aureus by large chromosomal replacements. J Bacteriol. 186(4), pp.1060-1064.
DA. Robinson, MC. Enright (2004). Multilocus sequence typing and the evolution of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect. 10(2), pp.92-97.
DA. Robinson, MC. Enright (2003). Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 47(12), pp.3926-3934.
R. Canton, M. Morosini, MC. Enright, I. Morrissey (2003). Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme. J Antimicrob Chemother. 52(6), pp.944-952.
H. Wisplinghoff, AE. Rosato, MC. Enright, M. Noto, W. Craig, et al. GL. Archer. (2003). Related clones containing SCCmec type IV predominate among clinically significant Staphylococcus epidermidis isolates. Antimicrob Agents Chemother. 47(11), pp.3574-3579.
M. Ip, DJ. Lyon, F. Chio, MC. Enright, AF. Cheng (2003). Characterization of isolates of methicillin-resistant Staphylococcus aureus from Hong Kong by phage typing, pulsed-field gel electrophoresis, and fluorescent amplified-fragment length polymorphism analysis. J Clin Microbiol. 41(11), pp.4980-4985.
MC. Enright (2003). The evolution of a resistant pathogen--the case of MRSA. Curr Opin Pharmacol. 3(5), pp.474-479.
F. Vandenesch, T. Naimi, MC. Enright, G. Lina, GR. Nimmo, et al. H. Heffernan, N. Liassine, M. Bes, T. Greenland, ME. Reverdy, J. Etienne. (2003). Community-acquired methicillin-resistant staphylococcus aureus carrying panton-valentine leukocidin genes: Worldwide emergence. Emerging Infectious Diseases. 9(8), pp.978-984.
WB. van Leeuwen, C. Jay, S. Snijders, N. Durin, B. Lacroix, et al. HA. Verbrugh, MC. Enright, A. Troesch, A. van Belkum. (2003). Multilocus sequence typing of Staphylococcus aureus with DNA array technology. J Clin Microbiol. 41(7), pp.3323-3326.
EJ. Feil, JE. Cooper, H. Grundmann, DA. Robinson, MC. Enright, et al. T. Berendt, SJ. Peacock, JM. Smith, M. Murphy, BG. Spratt, CE. Moore, NPJ. Day. (2003). How clonal is Staphylococcus aureus?. J Bacteriol. 185(11), pp.3307-3316.
E. Meats, AB. Brueggemann, MC. Enright, K. Sleeman, DT. Griffiths, et al. DW. Crook, BG. Spratt. (2003). Stability of serotypes during nasopharyngeal carriage of Streptococcus pneumoniae. J Clin Microbiol. 41(1), pp.386-392.
H. Grundmann, S. Hori, MC. Enright, C. Webster, A. Tami, et al. EJ. Feil, T. Pitt. (2002). Determining the genetic structure of the natural population of Staphylococcus aureus: a comparison of multilocus sequence typing with pulsed-field gel electrophoresis, randomly amplified polymorphic DNA analysis, and phage typing. J Clin Microbiol. 40(12), pp.4544-4546.
MC. Enright, DA. Robinson, G. Randle, EJ. Feil, H. Grundmann, et al. BG. Spratt. (2002). The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A. 99(11), pp.7687-7692.
A. Kalia, BG. Spratt, MC. Enright, DE. Bessen (2002). Influence of recombination and niche separation on the population genetic structure of the pathogen Streptococcus pyogenes. Infect Immun. 70(4), pp.1971-1983.
NPJ. Day, CE. Moore, MC. Enright, AP. Berendt, JM. Smith, et al. MF. Murphy, SJ. Peacock, BG. Spratt, EJ. Feil. (2002). Retraction. Science. 295(5557), pp.971-971.
A. Kalia, MC. Enright, BG. Spratt, DE. Bessen (2001). Directional gene movement from human-pathogenic to commensal-like streptococci. Infect Immun. 69(8), pp.4858-4869.
NP. Day, CE. Moore, MC. Enright, AR. Berendt, JM. Smith, et al. MF. Murphy, SJ. Peacock, BG. Spratt, EJ. Feil. (2001). A link between virulence and ecological abundance in natural populations of Staphylococcus aureus. Science. 292(5514), pp.114-116.
MC. Enright, BG. Spratt, A. Kalia, JH. Cross, DE. Bessen (2001). Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone. Infect Immun. 69(4), pp.2416-2427.
W. Witte, M. Enright, FJ. Schmitz, C. Cuny, C. Braulke, et al. D. Heuck. (2001). Characteristics of a new epidemic MRSA in Germany ancestral to United Kingdom EMRSA 15. Int J Med Microbiol. 290(8), pp.677-682.
EJ. Feil, EC. Holmes, DE. Bessen, MS. Chan, NP. Day, et al. MC. Enright, R. Goldstein, DW. Hood, A. Kalia, CE. Moore, J. Zhou, BG. Spratt. (2001). Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences. Proc Natl Acad Sci U S A. 98(1), pp.182-187.
MC. Enright, K. Knox, D. Griffiths, DW. Crook, BG. Spratt (2000). Molecular typing of bacteria directly from cerebrospinal fluid. Eur J Clin Microbiol Infect Dis. 19(8), pp.627-630.
EJ. Feil, JM. Smith, MC. Enright, BG. Spratt (2000). Estimating recombinational parameters in Streptococcus pneumoniae from multilocus sequence typing data. Genetics. 154(4), pp.1439-1450.
MC. Enright, NP. Day, CE. Davies, SJ. Peacock, BG. Spratt (2000). Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol. 38(3), pp.1008-1015.
J. Zhou, MC. Enright, BG. Spratt (2000). Identification of the major Spanish clones of penicillin-resistant pneumococci via the Internet using multilocus sequence typing. J Clin Microbiol. 38(3), pp.977-986.
EJ. Feil, MC. Enright, BG. Spratt (2000). Estimating the relative contributions of mutation and recombination to clonal diversification: a comparison between Neisseria meningitidis and Streptococcus pneumoniae. Res Microbiol. 151(6), pp.465-469.
MC. Enright, BG. Spratt (1999). Multilocus sequence typing. Trends Microbiol. 7(12), pp.482-487.
MC. Enright, BG. Spratt (1999). Extensive variation in the ddl gene of penicillin-resistant Streptococcus pneumoniae results from a hitchhiking effect driven by the penicillin-binding protein 2b gene. Mol Biol Evol. 16(12), pp.1687-1695.
MC. Enright, A. Fenoll, D. Griffiths, BG. Spratt (1999). The three major Spanish clones of penicillin-resistant Streptococcus pneumoniae are the most common clones recovered in recent cases of meningitis in Spain. J Clin Microbiol. 37(10), pp.3210-3216.
TJ. Coffey, M. Daniels, MC. Enright, BG. Spratt (1999). Serotype 14 variants of the Spanish penicillin-resistant serotype 9V clone of Streptococcus pneumoniae arose by large recombinational replacements of the cpsA-pbp1a region. Microbiology (Reading). 145 ( Pt 8)(8), pp.2023-2031.
ZY. Shi, MC. Enright, P. Wilkinson, D. Griffiths, BG. Spratt (1998). Identification of three major clones of multiply antibiotic-resistant Streptococcus pneumoniae in Taiwanese hospitals by multilocus sequence typing. J Clin Microbiol. 36(12), pp.3514-3519.
MC. Enright, BG. Spratt (1998). A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology (Reading). 144 ( Pt 11)(11), pp.3049-3060.
TJ. Coffey, MC. Enright, M. Daniels, JK. Morona, R. Morona, et al. W. Hryniewicz, JC. Paton, BG. Spratt. (1998). Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae. Mol Microbiol. 27(1), pp.73-83.
TJ. Coffey, MC. Enright, M. Daniels, P. Wilkinson, S. Berrón, et al. A. Fenoll, BG. Spratt. (1998). Serotype 19A variants of the Spanish serotype 23F multiresistant clone of Streptococcus pneumoniae. Microb Drug Resist. 4(1), pp.51-55.
M. Enright, P. Zawadski, P. Pickerill, CG. Dowson (1998). Molecular evolution of rifampicin resistance in Streptococcus pneumoniae. Microb Drug Resist. 4(1), pp.65-70.
MC. Enright, H. McKenzie (1997). Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen. J Med Microbiol. 46(5), pp.360-371.
MC. Enright, PE. Carter, IA. MacLean, H. McKenzie (1994). Phylogenetic relationships between some members of the genera Neisseria, Acinetobacter, Moraxella, and Kingella based on partial 16S ribosomal DNA sequence analysis. Int J Syst Bacteriol. 44(3), pp.387-391.
SJ. Richards, AP. Greening, MC. Enright, MG. Morgan, H. McKenzie (1993). Outbreak of Moraxella catarrhalis in a respiratory unit. Thorax. 48(1), pp.91-92.
H. McKenzie, MG. Morgan, JZ. Jordens, MC. Enright, M. Bain (1992). Characterisation of hospital isolates of Moraxella (Branhamella) catarrhalis by SDS-PAGE of whole-cell proteins, immunoblotting and restriction-endonuclease analysis. J Med Microbiol. 37(1), pp.70-76.
MG. Morgan, H. McKenzie, MC. Enright, M. Bain, FX. Emmanuel (1992). Use of molecular methods to characterize Moraxella catarrhalis strains in a suspected outbreak of nosocomial infection. Eur J Clin Microbiol Infect Dis. 11(4), pp.305-312.
MG. Morgan, C. Stuart, AT. Leanord, M. Enright, GF. Cole (1992). Citrobacter diversus brain abscess: case reports and molecular epidemiology. J Med Microbiol. 36(4), pp.273-278.
DR. Harper, M. McConville, FJ. Anderson, MC. Enright (2015). Antimicrobial Phages. In: Molecular Medical Microbiology. Elsevier, pp.567-581.
PJ. White, MC. Enright (2010). Mathematical models in infectious disease epidemiology. In: Infectious Diseases. Elsevier, pp.70-75.
MC. Enright, W. Witte (2004). Epidemiology of MRSA and MSSA. In: Staphylococcus Aureus. Elsevier, pp.31-65.
Harper, D.R., M. McConville, J. Anderson and M.C. Enright. 2014. Antimicrobial phages. In Molecular Medical Microbiology 2nd Ed. Elsevier publishing.
Parracho H.M., Burrowes, M.C. Enright, M.L. McConville and D.R. Harper. 2012. The role of regulated clinical trials in the development of bacteriophage therapeutics. J. Mol. Genet. Med. 26:279-86.
Enright, M.C. and B.G. Spratt. 2011. The genomic view of bacterial diversification. Science. 331:407-9.
Harper D.R., J. Anderson and M.C. Enright. 2011. Phage therapy: delivering on the promise. Ther Deliv. 2011 Jul;2:935-47. Burrowes, B., D.R. Harper, J. Anderson, M. McConville and M.C. Enright. 2011.
Bacteriophage therapy: potential uses in the control of antibiotic resistant pathogens. Exp. Rev. Anti-infect. Ther. 9:775-85. Enright, M.C. and D.R. Harper. 2011.
Bacteriophages for the treatment of Pseudomonas aeruginosa infections. J. Appl. Microbiol. 111:1-7.
Adams-Howell, P., M. Bhabra, M.C. Enright, M. Kiernan, Shyam Kolkevar, and P. Trueman. 2011. ‘Under the knife: Taking a zero tolerance approach to preventable surgical site infections in UK hospitals. An independent report initiated and funded by CareFusion.
White, P.J. and M.C. Enright. 2010. Mathematical models in infectious disease epidemiology. In Infectious Diseases. Third Edition. Eds J. Cohen and W. Powderly. Elsevier publishing. Enright, M.C. 2008.
The population structure of Staphylococcus aureus. In Staphylococci: Molecular Genetics. Ed. J. Lindsay. Horizon Scientific Press. Enright, M.C. 2007.
The Pneumococcus: population biology and virulence In Introduction to Evolutionary Biology of Bacterial and Fungal Pathogens. 2007. Eds F. Baquero, C. Nombela, G. Cassell and Jose Gutierrez-Fuentes. Blackwell Publishing. Enright, M.C. 2007. MRSA – the hospital superbug goes public. Public services review (issue 9).
Enright, M. C. 2006. Genome of an epidemic community-acquired MRSA. Lancet 367:705-6. Enright, M. 2005.
On why politics and MRSA don’t mix. 2005. Health Serv. J. 115:35.
Enright, M. 2005. MRSA – a national disgrace? Microbiology Today (February). Feil, E.J. and M.C. Enright. 2004.
Bacterial pathogen clonality and evolution analysis. Curr. Op. Microbiol. 7:308-13. Enright, M.C. and W. Witte.
Epidemiology of MRSA and MSSA. 2004. In: Staphylococcus aureus: molecular and clinical aspects. (K. Hiramatsu and D. Ala’Aldeen (Eds.) Horwood Publishing, Chichester, UK.
Robinson, D.A. and M.C. Enright. 2004. Multilocus sequence typing and the evolution of MRSA. Clin. Microb. Infect. 10:92-7. *summary of paper published in 2004, Emerg Infect Dis 10:971.
Enright, M.C. The evolution of a resistant pathogen – the case of MRSA. 2003. Curr. Opinion. Pharmacol. 3:474-9. Enright, M.C.
The evolution and spread of MRSA clones. 2003. In: Hospital Decisions International. Sovereign Publications Ltd. London, UK.
Enright M., P. Zawadski, P. Pickerill, and C.G. Dowson. 2000. Molecular evolution of rifampicin resistance in Streptococcus pneumoniae. In: Streptococcus pneumoniae: molecular biology and mechanisms of disease. A. Tomasz (ed.). Mary Ann Liebert, Inc. Publishers, Larchmont, USA. Enright M.C. and B.G. Spratt. 1999.
Multilocus sequence typing: tracking the global spread of antibiotic-resistant and hyper-virulent strains of bacteria. Trends. Microbiol. 7:482-7.
Enright M.C., and H. McKenzie. 1997. Moraxella (Branhamella) catarrhalis-clinical and molecular aspects of a rediscovered pathogen. J. Med. Microbiol. 46: 360-371.
Editor, International Journal of Antimicrobial Agents
Section Editor, FEMS Microbiology Letters
Member of the editorial board:
Antibiotics (2019-date)
PeerJ (2017-date)
Journal of Clinical Microbiology (2007-12)
Philosophical Transactions of the Royal Society B (2009-14)
Microbial Drug Resistance (2010-15).
Reviewer for publications including Science, Nature, Proc. Natl. Acad. Sci. (USA) etc
Expert reviewer for many grant award bodies including The Wellcome Trust, MRC, European Union, Innovate UK, Health Research Board, Ireland.
Last Five Years:
CONFAP / Newton Fund Research Mobility Award. (Oct 2019 – Mar 2020). £19,800. To fund sabbatical visit to Sao Paulo Oct 2019 - Mar 2020.
BBSRC / Newton Fund award with FAPESP (São Paulo Research Foundation). Xanthomonas citri subsp. citri citrus canker in São Paulo. Molecular epidemiology and biocontrol potential of bacteriophage and their depolymerases’. 2019-21. £350,613. Principal Investigator.
BBSRC / Newton Fund pump-priming award with FAPESP. ‘Xanthomonas citri subsp citri citrus tree cankers in São Paulo : molecular epidemiology and assessment of lytic bacteriophage as biocontrol agents’. 2018-19. £76,980. Principal Investigator.
EU Framework 7; Marie Curie IAPP award (with Brighton University and University College Cork) ‘Bacteriophage therapy for catheter infection control (BATCIC)’. 2012-2015. €1.1m.
Technology Strategy Board award (with Unilever, Universities of Liverpool and Glasgow and Skalene Technologies). ‘Genomes: UK’ ‘Development of instrumental and bioinformatic pipelines to accelerate commercial applications of metagenomics approaches’. 2011-2014. £2.3m. Industrial Principal Investigator.
EPSRC Healthcare partnership grant (with Bath University). ‘Encapsulated phage for treatment of burns and wound site infections. 2011 – 2015. £620 000. Ampliphi Biosciences Principal Investigator.
BBSRC CASE Studentship award (with Bath University) Bacteriophage based therapeutics to treat gram negative pathogens. 2011 – 2015. £84 000.
Royal Society University Research Fellowship 2000-8.
European Society for Clinical Microbiology and Infectious Disease Young Investigator Award 2002.
The Wellcome Trust, MRC, BBSRC, Innovate UK, EU, Health Research Board, Ireland.
Visiting Professor, University of Bath, Department of Chemistry, Bath, BA2 7AY. (Sep 2011 - Aug 2014).
PeerJ
International Journal of Antimicrobial Agents
FEMS Microbiology Letters